DATE : 2023-05-01
ATTENDEES : PERSON175, PERSON176, PERSON177, PERSON178, PERSON179, PERSON180, PERSON181, PERSON182, PERSON184, PERSON185, PERSON186, PERSON187, PERSON188, PERSON189, PERSON190, PERSON191, PERSON192, PERSON193, PERSON194, PERSON195, PERSON987, PERSON988, PERSON989, PERSON990


SUMMARY
- The next item is the debate on the oral question to the Council on joint programming of research to combat neurodegenerative diseases.
- Herbert Reul may be late and may be given the floor at the end.
- Parliament wants to know if the Council can confirm its intention to adopt conclusions on neurodegenerative diseases during the Competitiveness Council of 3 December 2009.
- They also want to know about future joint programming of research activities.
- The proposal for a Council Recommendation on measures to combat neurodegenerative diseases, in particular Alzheimer's, which was adopted by the Commission on 22 July, is based on Article 165 of the Treaty on Economic Cooperation and Development.
- Article 165 provides a legal basis for the Commission to take possible initiatives The Swedish Presidency wishes to adopt in December the conclusions regarding the measures to combat neurodegenerative diseases without waiting for Parliament's opinion.
- It is important that Parliament's position is taken into account when drafting the Council's conclusions.
- The initiative concerning the fight against neurodegenerative diseases is important for two reasons: the subject of the research and the joint programming methods for the research.
- Parliament would have preferred Parliament to be more directly involved in the pilot project.
- They ask for guarantees that their opinion will be taken into The Group of the United European Left - Nordic Green Left has tabled a motion for the research results to be made publicly available.
- According to the rapporteur, there should be a proper balance between prevention and adaptation of Alzheimer's disease.
- Member States should work together effectively.
- Finally, they should invest more in research into Alzheimer's diseases.
- PERSON182 supports the idea of joint programming of research on neurodegenerative diseases.
- He would like to know whether the recommendations tabled by the Parliament will be taken into consideration.
- The European Parliament will not be consulted on the Commission's new proposals on Alzheimer's disease.
- PERSON187: Madam President, coordinating research in the area of Alzheimer's disease is really important.
- Parliament has a significant role to play in how that research will be done.
- MEPs hope to have an early agreement at second reading on animal welfare law.
- The European Union unites 27 member states in combating neurodegenerative diseases, especially Alzheimer's disease.
- The priority should be on prevention and not medication.
- The Member States should set up monitoring centres for patients and their carers.
- There should be equal scientific participation by the Member States in The European Council will adopt conclusions on Alzheimer's disease on 3 December, based on the resolution presented by PERSON192.
- PERSON990 supports the Commission's proposal for a pilot project for research in the area of neurodegenerative diseases.
- The Commission should consider using Article 182(5) of the Treaty on the Functioning of the European Union as a legal basis for future joint programming of research activities in the field of neurodegenerative diseases.
- Alzheimer's disease is a confusing illness that changes the sufferer's world into somewhere unknown and perilous.
- There is no known cure for the disease.
- As the population ages in Europe, neurodegenerative diseases such as Alzheimer's and Parkinson's are becoming more and more a public health The European Commission adopted the Council's recommendation for joint programming of research into neurodegenerative diseases.
- Europe needs a more extensive action programme on dementia.
- Member States need to step up their information campaigns regarding an active lifestyle.


Minuted by: Team Synapse